1. Инструкция по медицинскому применению лекарственного препарата Аугментин ЕС (порошок для приготовления суспензии для приема внутрь). Регистрационное удостоверение ЛСР003616/10 от 15.04.20; 2. Dagan R et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20(9): 829–837; 3. Schrag SJ, Pena C, Fernandez J. Effect of Short-Course, High-Dose Amoxicillin Therapy on Resistant Pneumococcal Carriage. JAMA 2001; 286:49-56; 4. White AR, Kaye C., Poupard J et al. Augmentin® (amoxicillin-clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. Journal Antimicrobial Chemotherapy 2004 53 suppl SI, i3-i20; 5. Working Group of the Infectious Diseases Society of Southern Africa. Updated guideline for the management of upper respiratory tract infections in South Africa: 2008. South Afr J Epidemiol Infect 2008;23(4):01-09; 6. Hoberman A et al. Large Dosage Amoxicillin/Clavulanate, Compared With Azithromycin, for the Treatment of Bacterial Acute Otitis Media in Children. Pediatric Infectious Disease Journal. 2005 24(6):525-532; 7. Data on file. Study 574 (AE0304), Study 382 (AE0305). GlaxoSmithKline; 8. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53(7):e25–76; 9. Chow A, Benninger M, Brook I IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults Clin Infect Dis. (2012) 54(8): e72-e112; 10. Lieberthal A, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics 2013;131:e964–e999; 11. Shulman ST, Bisno AL, Clegg HW, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clin Infect Dis 2012;55(10):1279–1282; 12. Torumkuney D, Nica M, Nistor I, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Bulgaria, Romania, Serbia and Croatia. J Antimicrob Chemother 2018;73(Suppl 5):v2–v13; 13. Torumkuney D, Mayanskiy N, Edelstein M, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Russia. J Antimicrob Chemother 2018;73(Suppl 5):v14–v21; 14. Torumkuney D, Zemlickova H, Maruscak M, Morrissey I. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in the Czech Republic. J Antimicrob Chemother 2018;73(Suppl 5):v22–v27; 15. Torumkuney D, Pertseva T, Bratus E, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Ukraine and the Slovak Republic. J Antimicrob Chemother 2018;73(Suppl 5):v28–v35; 16. Torumkuney D, Papaparaskevas J, Morrissey I. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Greece. J Antimicrob Chemother 2018;73(Suppl 5):v36–v42; 17. Инструкция по медицинскому применению препарата Аугментин, порошок для приготовления суспензии для приема внутрь – регистрационное удостоверение П N 015030/04 от 30.12.19